{"id":"W2804336813","doi":"10.1136/jnnp-2018-anzan.60","title":"061 Ocrelizumab reduces disability progression independent of relapse activity in patients with relapsing multiple sclerosis (RMS) (ENCORE)","year":2018,"lang":"en","type":"article","venue":"Journal of Neurology Neurosurgery & Psychiatry","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Ocrelizumab; Expanded Disability Status Scale; Medicine; Multiple sclerosis; Internal medicine; Interferon beta-1a; Oncology; Interferon beta; Gastroenterology; Immunology; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004075647,0.0002898393,0.0005927611,0.0001402403,0.00010577,0.000278449,0.0001632784,0.0002438422,0.002407496],"category_scores_gemma":[0.0004027746,0.00007978988,0.0004189785,0.00009965606,0.0001028664,0.0001570157,0.0001507914,0.0004151519,0.0003021],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002420246,"about_ca_system_score_gemma":0.0003098982,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007846428,"about_ca_topic_score_gemma":0.003167922,"domain_scores_codex":[0.9998832,0.00003117862,0.00001354319,0.0000187515,0.00002247522,0.00003075229],"domain_scores_gemma":[0.9998088,0.00003440207,0.00005771337,0.00001224449,0.00002858572,0.00005823041],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1789106,0.006751554,0.06391422,0.002094438,0.00147508,0.000594101,0.0002547581,0.001033904,0.05324663,0.0002799929,0.01310389,0.6783408],"study_design_scores_gemma":[0.1076903,0.2909285,0.5384603,0.0007853782,0.002838893,0.003361559,0.0003026884,0.004207529,0.01920829,0.000403314,0.03174518,0.00006809397],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901202,0.005567011,0.0001213917,0.0002945349,0.00006543831,0.0001321968,0.000505329,0.00008286028,0.00311102],"genre_scores_gemma":[0.995764,0.001051073,0.0003655557,0.0003207665,0.00006264346,0.00008311115,0.0006834846,0.000006433167,0.00166287],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002407496,"threshold_uncertainty_score":0.008053839,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01607467090997377,"score_gpt":0.253577009761121,"score_spread":0.2375023388511472,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}